If the product is as good as they claim, why have they not sold any in Europe?
I bought in a few months ago on a recommendation, and liked the tech as I'm in the age bracket that this is aimed at. Definitely prefer a blood test, than crap in a bag. However don't see were the hold up is? Any thoughts?
Ann: Appendix 4C - quarterly, page-18
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RHY (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.93M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 141372 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.0¢ | 4216 | 1 |
View Market Depth
| Last trade - 10.06am 06/08/2024 (20 minute delay) ? |
| RHY (ASX) Chart |
Day chart unavailable